Blueprint Medicines Corp at Barclays Global Healthcare Conference Transcript
Perfect. Good afternoon. Welcome to Barclays Global Healthcare Conference in Miami. Do e-mail us or associates to self-online as well on Bloomberg, and if you have questions. My name is Peter Lawson. I'm one of the mid-cap biotech analyst at Barclays, and really delighted, as I have up on stage with us management from Blueprint Medicines and so we've got Mike Landsittel, CFO; and Becker Hewes, Chief Medical Officer.
Questions & Answers
And I guess first kind of question is just around how we should think about -- how quickly you can get to market post PDUFA kind of thing?
Yes. So thanks, Peter. First of all, thanks for having us. And on behalf of Blueprint, it's great to participate in this conference. With respect to AYVAKIT, so we have a PDUFA date scheduled for May 22 of this year, so that's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |